Position in MRK
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$7,340,048
+$432,876 QoQ
Shares Held
57,121
-0.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.89%
of 13F equity value
Holder Rank
#865
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Derivatives in MRK
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$105,260
PutShares
1,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rossmore Private Capital holds $82,109,326 across 11 Drug Manufacturers - General names. MRK ranks #4 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
100,877 | $25,619,731 | |
| 2 | LLY |
ELI LILLY & Co
|
20,769 | $24,910,963 | |
| 3 | ABBV |
AbbVie Inc.
|
46,722 | $11,757,124 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
57,121 | $7,340,048 | |
| 5 | AZN |
Astrazeneca PLC
|
37,843 | $7,175,789 | |
| 6 | AMGN |
Amgen Inc
|
5,635 | $2,040,546 | |
| 7 | NVO |
Novo Nordisk A S
|
23,000 | $1,102,620 | |
| 8 | NVS |
Novartis AG
|
4,581 | $717,934 |
All Filings in MRK
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,340,048 | 57,121 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $6,907,172 | 57,421 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $105,260 | 1,000 | Put | Sole | 2026-02-05 | |
| 2025-12-31 | $7,061,051 | 67,082 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $5,252,171 | 62,578 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $5,272,847 | 66,610 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $6,430,047 | 71,636 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,192,801 | 72,304 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $8,278,296 | 72,898 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $8,971,538 | 72,468 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $9,664,941 | 73,247 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $8,009,372 | 73,467 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $7,579,076 | 73,619 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,490,742 | 73,583 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,563,371 | 71,091 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $7,918,390 | 71,369 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,178,421 | 71,742 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $6,352,178 | 69,674 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $5,555,031 | 67,703 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $5,354,760 | 69,869 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $3,987,665 | 53,091 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $4,087,280 | 52,556 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,052,546 | 52,569 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $5,054,501 | 61,791 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $4,895,628 | 59,019 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $3,739,603 | 48,359 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $3,411,056 | 44,334 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||